CDR2 Antikörper (C-Term)
Kurzübersicht für CDR2 Antikörper (C-Term) (ABIN5533936)
Target
Alle CDR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 420-448, C-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This CDR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 420-448 amino acids from the C-terminal region of human CDR2.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Andere Bezeichnung
- CDR2
-
Molekulargewicht
- 52 kDa
-
Gen-ID
- 101060399, 1039
-
UniProt
- Q01850
Target
-